Pennsylvania
Pennsylvania Republicans should move on from Doug Mastriano
Former Pennsylvania gubernatorial candidate and state Sen. Doug Mastriano is expected to announce his decision Thursday night whether he will be running for U.S. Senate and oppose incumbent Sen. Bob Casey (D-PA) in the 2024 election. He stated earlier this week that he would do a Facebook Live event on Thursday evening. But if Republicans want to have any chance at reclaiming a seat in the Senate, voters should move on from Mastriano.
Mastriano has shown he cannot win in a general election. He was trounced in the 2022 gubernatorial election by Josh Shapiro, obtaining less than 42% of all votes and losing by nearly 1 million. This was telling, given that Pennsylvania voted for Donald Trump in 2016 and in 2020 voted for Joe Biden but only by a narrow margin of 1.2%. Mastriano is an ardent supporter of strong conservative values, which is a positive. However, he routinely stumbled in getting his message across, especially to independents.
BIDEN AND REPUBLICANS BLAME EACH OTHER FOR DEFAULT THEY INSIST WON’T HAPPEN
Mastriano did win most of the Keystone State’s rural counties but, like nearly every Republican candidate, struggled immensely in urban areas such as Pittsburgh, Harrisburg, Philadelphia, and their surrounding counties. Going against an established candidate such as Casey, whose father was also a relatively beloved governor of the state, will yield only more disastrous results this time around if Mastriano is the Republican candidate.
Additionally, Mastriano ran a terrible campaign. It was disorganized, chaotic, and inefficient, and there has not been anything to suggest the 2024 version would be any different, even though, admittedly, it might be too early to make such a statement. His campaign was too reluctant to confront the legacy media, somewhat understandable given their lack of objectivity and strong left-wing positions, but also fumbled many opportunities with media representatives more aligned with his values.
CLICK HERE TO READ MORE FROM THE WASHINGTON EXAMINER
Most importantly, it should be acknowledged that Casey represents a formidable foe in the election. Incumbents enjoy a significant advantage in elections and, most of the time, get reelected. Add in the fact that Casey isn’t really a controversial political figure who could rile up a Republican base, and it’s going to be a tall task to try to defeat him. Republican voters would be better suited to find another candidate who supports their values and stands up to left-wing attacks but also runs an efficient campaign and effectively delivers his or her political message to voters. By all available evidence, Mastriano isn’t that person.
Pennsylvania
Model Dayle Haddon dies after suspected carbon monoxide leak in Pennsylvania home
Model, actress and humanitarian Dayle Haddon died Friday after what police believe was a carbon monoxide leak at a Bucks County, Pennsylvania, home.
Police from Solebury Township in Bucks County, which is in the Philadelphia metropolitan area, began investigating a property at 6:30 a.m. Friday, after a resident called 911 to report a 76-year-old man was lying down, passed out on the first floor of a detached “in-law” suite.
The man was taken to Robert Wood Johnson University Hospital in New Brunswick, New Jersey, according to the police report. His condition was not immediately available. A second victim, a 76-year-old woman, was found dead in the detached suite’s second-floor bedroom.
Eliot Gross, the deputy coroner of Bucks County, confirmed to USA TODAY that the female victim was Haddon. Toxicology reports to determine the cause of death are expected on Saturday, according to Gross.
Volunteer firefighters on the scene detected a “high level of carbon monoxide” in the property, according to the police report. Two medics were transferred to the hospital for carbon monoxide exposure, and one was treated on the scene.
CBS News reported that the home is owned by Haddon’s daughter, former journalist Ryan Haddon, and Ryan’s husband, the actor Marc Blucas.
The Canadian-born Haddon was one of the top models in the 1970s, posing on the cover of the 1973 Sports Illustrated Swimsuit issue. Haddon starred in the 1973 Disney movie “The World’s Greatest Athlete” and in Hollywood films such as 1979’s football satire “North Dallas Forty” along with Nick Nolte.
Haddon worked as L’Oréal spokesperson and was the author of “Ageless Beauty: A Woman’s Guide to Lifelong Beauty and Well-Being.”
Haddon traveled the world as an ambassador for the humanitarian aid organization UNICEF. She is also the founder of WomenOne, a charity focused on creating educational opportunities for girls and women, according to her website.
Pennsylvania
BioNTech settles with U.S. agency, University of Pennsylvania over Covid vaccine royalties
Vials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.
Rodrigo Garrido | Reuters
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University of Pennsylvania over the payment of royalties related to its COVID-19 vaccine, the company said in filings.
The German company, which partners with U.S. drugmaker Pfizer for its COVID-19 vaccine, said on Friday it would pay $791.5 million to the U.S. agency to resolve a default notice.
Separately, the company will pay $467 million to the University of Pennsylvania (Penn), which has agreed to dismiss a lawsuit brought against the vaccine maker accusing it of underpaying royalties.
BioNTech said partner Pfizer will reimburse it for up to $170 million of the royalties payable to Penn and $364.5 million of the royalties paid to the National Institutes of Health (NIH)for 2020-2023 vaccine sales.
NIH and Penn did not immediately respond to requests for comment.
The U.S. government is owed royalty payments under the terms of the license BioNTech has taken for certain patents owned by the NIH, among other entities.
Penn’s lawsuit had said BioNTech owes the school a greater share of its worldwide vaccine sales for using “foundational” messenger RNA (mRNA) inventions developed by Penn professors and Nobel Prize winners Katalin Kariko and Drew Weissman.
The company also amended its license agreements with both NIH and Penn, agreeing to pay a low single-digit percentage of its vaccine net sales to both the entities.
Both settlements include a framework for a license to use NIH and Penn’s patents in combination products.
The agreements do not constitute an admission of liability in either case, the company said.
Pennsylvania
5 injured, several families displaced after rowhome fire in Allentown, Pennsylvania
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
-
Technology7 days ago
Google’s counteroffer to the government trying to break it up is unbundling Android apps
-
News1 week ago
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
-
Politics1 week ago
Illegal immigrant sexually abused child in the U.S. after being removed from the country five times
-
Entertainment1 week ago
'It's a little holiday gift': Inside the Weeknd's free Santa Monica show for his biggest fans
-
Lifestyle1 week ago
Think you can't dance? Get up and try these tips in our comic. We dare you!
-
Technology3 days ago
There’s a reason Metaphor: ReFantanzio’s battle music sounds as cool as it does
-
Technology1 week ago
Fox News AI Newsletter: OpenAI responds to Elon Musk's lawsuit
-
News4 days ago
France’s new premier selects Eric Lombard as finance minister